Brokerages Anticipate Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) to Post ($0.10) EPS

Two equities research analysts have rated the stock with a strong ... adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis and ...